Prashant Kohli
CIK: 0001946739
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Grace Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 9, 2026GRCE
Grace Therapeutics, Inc.
Purchase(P)Direct100K shares at avg. $2.14$214K - Aug 28, 2026GRCE
Grace Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
267.2K shares- - Apr 14, 2025GRCE
Grace Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
225.4K shares-
1-3 of 3 transactions
About Kohli Prashant
Kohli Prashant (SEC CIK 0001946739) files insider reports with the SEC as Chief Executive Officer of Grace Therapeutics, Inc. (GRCE).
Signal8 holds 3 ownership filings by Kohli Prashant, all Form 4s, filed between Apr 16, 2025 and Sep 10, 2026. Those filings report 3 transactions, from Apr 14, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kohli Prashant's filings is in PRINCETON, NJ.
Recent filings by Kohli Prashant
Other insiders filing for Grace Therapeutics, Inc. (GRCE)
- Opaleye Management Inc., 10% Owner
- NEUGEBOREN EDWARD, Director
- DAVIS A BRIAN, Director
- Kavuru Vimal, Director
- Kottayil George, Director
- Kumar Amresh, VP Program Management